focus -WSS

focus

author：knowledge 2025-09-28 21:11:43 - browse：42683

Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage — Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Do digital therapeutics have a future in medicine?

WSS

Time to name cancers by genetics, not organ of origin, expert says

Medicare slashes safety net hospital payments by nearly $1 billion

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Flint parents haunted by uncertainty, fears of lead poisoning

Commercial surrogacy can be ethical, despite pope’s claims

Physicians aren't 'burning out.' They're suffering from moral injury

entertainment

focus

explore

The high cost of giving birth even with insurance

New Ultima Genomics DNA sequencer can read genome for $100

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A $475,000 price tag for a new cancer drug: crazy or meh?

Sports medicine is finally prioritizing gender equality

Quicker fix for pulse oximeters urged during FDA public meeting

Jerome Adams on the need for new antivirals for Covid

Congressmen charge Covid hearing ‘could have been an email’

Continuity nursing helped my family in our darkest PICU moments

Group behind ProMed defends move to subscription

knowledge

When waiting feels immoral: Empathy in the emergency department

2 officers injured in shooting in Orlando, police say

H.R. 3 is the wrong path to lower drug costs

Woodcock on FDA’s accelerated approval and her next chapter

A controversial new treatment promises to make little people taller

Physicians aren't 'burning out.' They're suffering from moral injury

hotspot

knowledge

leisure time

hotspot